Between 2013 and 2022, systemic hormonal preparations sales in South Korea have shown substantial fluctuations, marked by a significant drop in 2016 and a strong recovery in 2021. The year-on-year variations for the past two years were 24.63% in 2021 and 4.08% in 2022. The compound annual growth rate (CAGR) over the last 5 years stands at 8.43%. Future projections estimate a steady growth pace with a forecasted 5-year CAGR of 2.42%, culminating in a 12.68% growth rate by 2028.
Future trends to watch include advancements in treatment technologies, regulatory changes, and demographic shifts impacting the market for systemic hormonal preparations in South Korea.
